DDAVP and Hemostasis

Wichai Prayoonwiwat

Authors

Wichai Prayoonwiwat หน่วยโลหิตวิทยา กองอายุรกรรม โรงพยาบาลพระมงกุฎเกล้า

Keywords:

-

Abstract

-

Downloads

Download data is not yet available.

References

Aledort LM. Treatment of von Willebrand's disease. Mayo Clin Proc 1991;66840-6.

Mannoci PM, Ruggeri ZM, Pareti FI, Capitanmio A. DDAVP: A new pharmacological approach to the management of haemophilia and von Wilebrand's disease. Lancet 1977;1:869-72.

Manncci PM. Desmopressin: A nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988;72:1449-55.

de la Fuente B, Kasper CK, Rickles FR, Hoyer LW. Response of patient with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med 1985;103:6-14.

Warrier Al, Lusher JM. DDAVP: a useful altemative to blood components in moderate hemophilia A and von Willebrand disease. J Pediatr 1983;102:228-33.

Mannucci PM, Canciani MT, Rota, Donovan BS. Response of factor Vill/von Willebrand factor toDDAVP in healthy subjects and patients with hemophila A and von Willebrand's disease. Br J Haematol 1981;47:283-93.

Mariana G, Ciavarella N, Mazzucconi MG, et al. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients. Clin Lab Haematol 1984;6:229-38.

Nilsson IM, Lethagen S. Current status of DDAVP formulations and their use. In: Lusher JM, Kessler CM, eds. Hemophilia and von Willebrand's Disease in the 1990s. Amsterdam: Flsevier Science Pub., 1991:443-53.

Kohler M, Hellstern P, Tarrach H, et al. Subcutaneous injection of desmopressin (DDAVP): evaluation of a new, more concentrate prepartion. Haemostasis 1989;1:38-44.

Harris AS, Nilsson IM, Wagner Z-G, Alkner U. Intranasal administration of peptides: nasal deposition, biological response, and absorption of

desmopressin. J Pharma Sci 1986;75:1085-8.